Evidence-based pharmacological therapies across NSAIDs, muscle relaxants, and neuropathic agents.
At Lupin, we deliver a comprehensive, patient-centric model that covers pain management and long-term musculoskeletal health support.
Evidence-based pharmacological therapies across NSAIDs, muscle relaxants, and neuropathic agents.
Solutions for acute, chronic, inflammatory, and neuropathic pain which also support postoperative recovery and injury-related pain.
Multimodal approaches including oral, topical, and combination therapies.
Targeted supplementation to strengthen bones and muscles.
Including osteoarthritis, joint degeneration, muscle spasm, and sarcopenia leading to pain, stiffness, and reduced mobility.
Osteoporosis and osteopenia associated with bone weakening and fracture-related pain.
Arthritis and autoimmune conditions causing persistent inflammation and discomfort.
Nerve-related pain including diabetic neuropathy and age-related neurological conditions.
Calcium and vitamin D deficiencies contributing to bone fragility, weakness, and associated pain.
Acute and chronic pain caused by injuries, trauma, dental issues, or long-term degenerative conditions.
Disclaimer: The content on this website/webpage relates to a specific therapy/therapeutic area and is intended solely for informational and educational purposes for healthcare professionals and patients across India and other global locations, is not intended to substitute professional medical advice, diagnosis, or treatment. Advice from a physician or other qualified healthcare professional must be sought for any queries regarding a medical condition or treatment. Information on this website/webpage should not be solely used or relied upon in the absence of or delay in receiving professional medical advice. While Lupin makes reasonable efforts to ensure that the information is accurate and up to date, it makes no representations or warranties regarding its completeness or accuracy and accepts no liability for reliance on such information. The information on this website/webpage is not a substitute for prescribing information or patient information leaflets accompanying any medicinal product. The information on this website/webpage is subject to change without notice and may not reflect the most current medical, scientific, or regulatory developments. All content on this website/webpage is the intellectual property of Lupin and shall not be reproduced, modified, distributed, or used for any commercial purpose without the prior written consent of Lupin.
Our portfolio is structured to address both immediate pain relief and long-term musculoskeletal health.
Our flagship analgesic brand is a leading combination therapy used across specialties. It combines aceclofenac, paracetamol, and serratiopeptidase, helping with symptomatic relief from painful conditions like arthritis, lower back pain, muscle spasm, post-operative pain, and dental pain.
This tablet is used to treat pain and inflammation resulting from musculoskeletal injuries.
A specialized range focused on pain associated with muscle spasm. It contains combinations of thiocolchicoside with aceclofenac or etoricoxib. The medication helps with
This combination medicine is used to relieve pain and is available in gel form. It works by blocking the release of certain chemical messengers that cause pain and inflammation. It also helps with blood circulation at the site of application and produces a cooling effect on the skin. It is known to treat localized musculoskeletal pain.
A combination tablet that helps in relieving pain and inflammation. Addresses inflammatory conditions including joint disorders such as rheumatoid arthritis, post-traumatic and post-operative painful conditions.
We have shaped a differentiated presence in pain management and bone health through trusted flagship brands, engagement with healthcare providers, and expansion across evolving pain therapies.
As musculoskeletal disorders and pain conditions continue to rise with aging populations and evolving lifestyles, the focus on ortho and pain management is shifting beyond symptomatic relief toward a more integrated and sustained approach.
At Lupin, our approach is centered on advancing multimodal pain management while simultaneously strengthening preventive bone and muscle health to address the root causes of discomfort. Our patient-centric strategy ensures not only fast-acting pain relief but also sustained well-being and improved patient outcomes across the continuum of care.
